Pe­ter Hecht re­cruits Bay­er/Shire vet An­dreas Busch for a top R&D post at his $175M biotech spin­out

Im­age: Pe­ter Hecht. IRON­WOOD

Pe­ter Hecht has been a busy man.

In the past two weeks he’s un­veiled a whop­ping $175 mil­lion raise and spun out a ful­ly formed biotech out of Iron­wood — Cy­cle­ri­on Ther­a­peu­tics — se­cur­ing a pub­lic list­ing for a com­pa­ny with 140 staffers and a pipeline of drugs pre­sent­ing 4 cat­a­lysts over the course of this year. And now he’s built out his top ex­ec­u­tive team af­ter woo­ing Bay­er/Shire vet An­dreas Busch to take the job of chief in­no­va­tion of­fi­cer.

Busch will be work­ing along­side CSO Mark Cur­rie.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER